Target intelligence / Profile preview

Penicillin-binding proteins 1 and 3 (PBP1 and PBP3) (PBP1/3)

Target
PBP1/3
Molecular classification
Enzyme, Transpeptidase, Glycosyltransferase, Penicillin-binding protein
01

Overview

Penicillin-binding proteins 1 and 3 (PBP1 and PBP3) are essential membrane-anchored enzymes in bacteria that play critical roles in the assembly and maintenance of the peptidoglycan cell wall (rcsb.org, wikipedia.org). PBP1, which includes the major isoforms PBP1a and PBP1b, is a bifunctional enzyme possessing both glycosyltransferase activity for glycan chain elongation and transpeptidase activity for peptide cross-linking (nih.gov, rcsb.org). In contrast, PBP3 is a class B transpeptidase primarily localized to the division septum, where it is indispensable for the process of septation; its inhibition results in the formation of long, non-dividing bacterial filaments (nih.gov, wikipedia.org). These proteins serve as the primary therapeutic targets for the beta-lactam class of antibiotics, including penicillins, cephalosporins, and carbapenems (rcsb.org, nih.gov). The drugs act as structural analogs of the D-alanyl-D-alanine substrate, covalently binding to the active site serine and irreversibly inactivating the enzyme (nih.gov, oup.com). Clinical resistance often arises through mutations in the genes encoding these PBPs, such as ponA and ftsI, which reduce the binding affinity of the antibiotics while maintaining enough enzymatic function for bacterial survival (nih.gov).

Other names
PBP1PBP3PBP1aPBP1bftsIponAponBmrcAmrcBpbpC
02

Mechanism of action

Covalent inhibition of the transpeptidase domain by forming a stable acyl-enzyme complex with the active site serine, which prevents the cross-linking of peptidoglycan strands and leads to cell wall instability and bacterial lysis.

03

Biological functions

Cell wall synthesisPeptidoglycan biosynthesisCell divisionCell elongationSeptation
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistance (target modification)Hypersensitivity (allergic reactions)Gastrointestinal dysbiosisJarisch-Herxheimer-like inflammatory response
06

Interacting drugs

Penicillin G

12 more in the full profile.

07

Biomarkers

PBP mutations (e.g., ftsI R504C, ponA substitutions)Minimum Inhibitory Concentration (MIC)PBP expression levelsPBP typing

Beyond the preview

Go deeper on Penicillin-binding proteins 1 and 3 (PBP1 and PBP3) (PBP1/3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding proteins 1 and 3 (PBP1 and PBP3) (PBP1/3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call